Brief: Kinnate Inc - In Connection With Plan, Expects To Incur One-Time Costs Of About $2.0 Million, Primarily In Q3, Relating To Severance And Related Benefits

Kinnate Biopharma

18/09/2023 22:25

Kinnate Biopharma Inc  KNTE.O :
    * KINNATE INC - IN CONNECTION WITH PLAN, EXPECTS TO INCUR
ONE-TIME
COSTS OF ABOUT $2.0 MILLION, PRIMARILY IN Q3, RELATING TO
SEVERANCE AND RELATED BENEFITS
    * KINNATE BIOPHARMA INC - CASH PAYMENTS RELATED TO EXPENSES
WILL
BE PAID OUT, AND PLAN IS EXPECTED TO BE COMPLETED, DURING Q4

Source text for Eikon:  ID: 
Further company coverage:  KNTE.O